GAD2 and type 1 diabetes mellitus: Furthermore, Rutman et al. demonstrated that EVs from human islets of Langerhan cells could activate B cells in T1DM patients to produce antibodies against glutamic acid decarboxylase 65 (GAD65), an early marker for beta cell destruction 116.